Herein, we report nanoformulations based on cationic phosphorus dendrimers designed either for Lyn knockdown by RNAi or for antitumor activity per se as well as present a biological evaluation of this platform on a collection of pathophysiological relevant in vitro disease models of brain tumor stem cells. This evidence concerns the gene LYN and brain neoplasm.